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Correction to: Transcriptome-wide study of
TNF-inhibitor therapy in rheumatoid
arthritis reveals early signature of successful
treatment
James Oliver1†, Nisha Nair1†, Gisela Orozco1, Samantha Smith1, Kimme L. Hyrich2,3, Ann Morgan4, John Isaacs5,6,
Anthony G. Wilson7, BRAGGSS, Anne Barton1,2† and Darren Plant1,2*†
Correction to: Arthritis Res Ther 23, 80 (2021)
https://doi.org/10.1186/s13075-021-02451-9
Following publication of the original article [1], the au-
thors reported an error in the spelling of the first author.
The surname “Oliver” has been spelt with capital ‘I’ for
India instead of an ‘l’ for Lima.
The original article has been corrected.
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